Fibroblast Growth Factor 2 Induces Increased Calvarial Osteoblast Proliferation and Cranial Suture Fusion

Ahmed S.A. , Gogal RM Jr. , Walsh J.E. . A new rapid and simple non-radioactive assay to monitor and determine the proliferation of lymphocytes: an alternative to [3H]thymidine incorporation assay. J Immunol Methods. 1994; 170: 211–224.

Anderson J. , Burns H.D. , Enriquez-Harris P. , Wilkie A.O.M. , Heath J.K. . Apert syndrome mutations in fibroblast growth factor receptor 2 exhibit increased affinity for FGF ligand. Hum Mol Genet. 1998; 7: 1475–1483.

Baird A. , Walicke P.A. . Fibroblast growth factors. Br Med Bull. 1989; 45: 438–452.

Bellows C.G. , Aubin J.E. , Heersche J.N. , Antosz M.E. . Mineralized bone nodules formed in vitro from enzymatically released rat calvaria cell populations. Calcif Tissue Int. 1986; 38: 143–154.

Bodo M. , Carinci F. , Baroni T. , Becchetti E. , Bellucci C. , Giammarioli M. , Pezzetti F. , Toguon M. , Carinci P. . Interleukin pattern of Apert fibroblasts in vitro. Eur J Cell Biol. 1998; 75: 383–388.

Bradley J.P. , Levine J.P. , Blewett C. , Krummel T. , McCarthy J.G. , Longaker M.T. . Studies in cranial suture biology: in vitro cranial suture fusion. Cleft Palate Craniofac J. 1996; 33: 150–156.

Canalis E. , Centrella M. , McCarthy T. . Effects of basic fibroblast growth factor on bone formation in vitro. J Clin Invest. 1988; 81: 1572–1577.

Coffin J.D. , Florkiewicz R.Z. , Neumann J. , Mert-Hopkins T. , Dorn G.W. , Lightfoot P. , German R. , Howles P.N. , Kier A. , O'Toole B.A. . Abnormal bone growth and selective translational regulation in basic fibroblast growth factor (FGF-2) transgenic mice. Mol Biol Cell. 1995; 6: 1861–1873.

Debiais F. , Hott M. , Graulet A.M. , Marie P.J. . The effects of fibroblast growth factor-2 on human neonatal calvaria osteoblastic cells are differentiation stage specific. J Bone Miner Res. 1998; 13: 645–654.

Fields R.D. , Lancaster M.V. . Dual-attribute continuous monitoring of cell proliferation/cytotoxicity. Am Biotechnol Lab. 1993; 11: 48–50.

Fragale A. , Tartaglia M. , Bernardini S. , Di Stasi A. , Di Rocco C. , Velardi F. , Teti A. , Bettaglia P. , Migliaccio S. . Decreased proliferation and altered differentiation in osteoblasts from genetically and clinically distinct craniosynostotic disorders. Am J Pathol. 1999; 154: 1465–1477.

Globus R.K. , Plouet J. , Gospodarowicz D. . Cultured bovine bone cells synthesize basic fibroblast growth factor and store it in their extracellular matrix. Endocrinology. 1989; 124: 1539–1547.

Greenwald J.A. , Mehrara B.J. , Spector J.A. , Warren S. , Crisera F. , Fagenholz P. , Bouletreau P. , Longaker M. . Regional differentiation of cranial suture-associated dura mater in vivo and in vitro: implications for suture fusion and patency. J Bone Miner Res. 2000; 15: 2413–2430.

Greenwald J.A. , Mehrara B.J. , Spector J.A. , Warren S. , Fagenholz P. , Smith L. , Bouletreau P. , Crisera F. , Ueno H. , Longaker M. . In vivo modulation of FGF biological activity alters cranial suture fate. Am J Pathol. 2001; 158: 441–452.

Gronowicz G.A. , Derome M.E. . Synthetic peptide containing Arg-Gly-Asp inhibits bone formation and resorption in a mineralizing organ culture system of fetal rat parietal bones. J Bone Miner Res. 1994; 9: 193–201.

Hurley M.M. , Abreu C. , Gronowicz G. , Kawaguchi H. , Lorenzo J. . Expression and regulation of basic fibroblast growth factor mRNA levels in mouse osteoblastic MC3T3-E1 cells. J Biol Chem. 1994; 269: 9392–9396.

Iseki S. , Wilkie A.O. , Heath J.K. , Ishimaru T. , Eto K. , Morriss-Kay G.M. . Fgfr2 and osteopontin domains in the developing skull vault are mutually exclusive and can be altered by locally applied FGF2. Development. 1997; 124: 3375–3384.

Iseki S. , Wilkie A.O. , Morriss-Kay G.M. . Fgfr1 and Fgfr2 have distinct differentiation- and proliferation-related roles in the developing mouse skull vault. Development. 1999; 126: 5611–5620.

Johnson D.R. , Hauser I.A. , Voll R.E. , Emmrich F. . Arterial and venular endothelial cell costimulation of cytokine secretion by human T cell clones. J Leukoc Biol. 1998; 63: 612–619.

Katoh R. , Urist M.R. . Surface adhesion and attachment factors in bone morphogenetic protein-induced chondrogenesis in vitro. Clin Orthop. 1993: 295–304.

Kim H.J. , Rice D.P. , Kettunen P.J. , Thesleff I. . FGF-, BMP- and Shh-mediated signalling pathways in the regulation of cranial suture morphogenesis and calvarial bone development. Development. 1998; 125: 1241–1251.

Lajeunie E. , Catala M. , Renier D. . Craniosynostosis: from a clinical description to an understanding of bone formation of the skull. Childs Nerv Syst. 1999; 15: 676–680.

Levine J.P. , Bradley J.P. , Roth D.A. , McCarthy J.G. , Longaker M.T. . Studies in cranial suture biology: regional dura mater determines overlying suture biology. Plast Reconstr Surg. 1998; 101: 1441–1447.

Lomri A. , Lemonnier J. , Hott M. , de Parseval N. , Lajeunie E. , Munnich A. , Renier D. , Marie P. . Increased calvaria cell differentiation and bone matrix formation induced by fibroblast growth factor receptor 2 mutations in Apert syndrome. J Clin Invest. 1998; 101: 1310–1317.

Mansukhani A. , Bellosta P. , Sahni M. , Basilico C. . Signaling by fibroblast growth factors (FGF) and fibroblast growth factor receptor 2 (FGFR2)-activating mutations blocks mineralization and induces apoptosis in osteoblasts. J Cell Biol. 2000; 149: 1297–1308.

Mehrara B.J. , Greenwald J. , Chin G.S. , Dudziak M. , Sagrioglu J. , Steinbrech D. , Saadeh P. , Gittes G. , Longaker M. . Regional differentiation of rat cranial suture-derived dural cells is dependent on association with fusing and patent cranial sutures. Plast Reconstr Surg. 1999; 104: 1003–1013.

Mehrara B.J. , Mackool R.J. , McCarthy J.G. , Gittes G.K. , Longaker M.T. . Immunolocalization of basic fibroblast growth factor and fibroblast growth factor receptor-1 and receptor-2 in rat cranial sutures. Plast Reconstr Surg. 1998; 102: 1805–1817; discussion 1818–1820.

Montero A. , Okada Y. , Tomita M. , Ito M. , Tsurukami H. , Nakamura T. , Doetschman T. , Coffin J. , Hurley M. . Disruption of the fibroblast growth factor-2 gene results in decreased bone mass and bone formation. J Clin Invest. 2000; 105: 1085–1093.

Moss M.L. . Growth of the calvaria in the rat: the determination of osseous morphology. Am J Anat. 1962; 94: 333.

Most D. , Levine J.P. , Chang J. , Sung J. , McCarthy J. , Schendel S. , Longaker M. . Studies in cranial suture biology: up-regulation of transforming growth factor-beta1 and basic fibroblast growth factor mRNA correlates with posterior frontal cranial suture fusion in the rat. Plast Reconstr Surg. 1998; 101: 1431–1440.

Moursi A.M. , Damsky C.H. , Lull J. , Zimmerman D. , Doty S. , Aota S. , Globus R. . Fibronectin regulates calvarial osteoblast differentiation. J Cell Sci. 1996; 109: 1369–1380.

Nimni M.E. . Polypeptide growth factors: targeted delivery systems. Biomaterials. 1997; 18: 1201–1225.

Noda M. , Vogel R. . Fibroblast growth factor enhances type beta 1 transforming growth factor gene expression in osteoblast-like cells. J Cell Biol. 1989; 109: 2529–2535.

Opperman L.A. , Adab K. , Gakunga P.T. . Transforming growth factor-beta 2 and TGF-beta 3 regulate fetal rat cranial suture morphogenesis by regulating rates of cell proliferation and apoptosis. Dev Dyn. 2000; 219: 237–247.

Opperman L.A. , Nolen A.A. , Ogle R.C. . TGF-beta 1, TGF-beta 2, and TGF-beta 3 exhibit distinct patterns of expression during cranial suture formation and obliteration in vivo and in vitro [see comments]. J Bone Miner Res. 1997; 12: 301–310.

Opperman L.A. , Passarelli R.W. , Morgan E.P. , Reintjes M. , Ogle R.C. . Cranial sutures require tissue interactions with dura mater to resist osseous obliteration in vitro. J Bone Miner Res. 1995; 10: 1978–1987.

Opperman L.A. , Persing J.A. , Sheen R. , Ogle R.C. . In the absence of periosteum, transplanted fetal and neonatal rat coronal sutures resist osseous obliteration. J Craniofac Surg. 1994; 5: 327–332.

Opperman L.A. , Sweeney T.M. , Redmon J. , Persing J.A. , Ogle R.C. . Tissue interactions with underlying dura mater inhibit osseous obliteration of developing cranial sutures. Dev Dyn. 1993; 198: 312–322.

Rice D.P. , Kim H.J. , Thesleff I. . Apoptosis in murine calvarial bone and suture development. Eur J Oral Sci. 1999; 107: 265–275.

Roth D.A. , Longaker M.T. , McCarthy J.G. , Rosen D. , McMullen H. , Levine J. , Sung J. , Gold L. . Studies in cranial suture biology: part I. Increased immunoreactivity for TGF-beta isoforms (beta 1, beta 2, and beta 3) during rat cranial suture fusion. J Bone Miner Res. 1997; 12: 311–321.

Scutt A. , Bertram P. . Basic fibroblast growth factor in the presence of dexamethasone stimulates colony formation, expansion, and osteoblastic differentiation by rat bone marrow stromal cells. Calcif Tissue Int. 1999; 64: 69–77.

Thompson D. , Jones B. , Hayward R. , Harkness W. . Assessment and treatment of craniosynostosis. Br J Hosp Med. 1994; 52: 17–24.

Wilkie A.O. . Craniosynostosis: genes and mechanisms. Hum Mol Genet. 1997; 6: 1647–1656.

Xu J. , Liu Z. , Ornitz D.M. . Temporal and spatial gradients of Fgf8 and Fgf17 regulate proliferation and differentiation of midline cerebellar structures. Development. 2000; 127: 1833–1843.

Yamaguchi T.P. , Rossant J. . Fibroblast growth factors in mammalian development. Curr Opin Genet Dev. 1995; 5: 485–491.

Zhou Y.X. , Xu X. , Chen L. , Li C. , Brodie S.G. , Deng C.X. . A Pro250Arg substitution in mouse Fgfr1 causes increased expression of Cbfa1 and premature fusion of calvarial sutures. Hum Mol Genet. 2000; 9: 2001–2008.